FDA approved two anti-COVID-19 drugs and authorized others for emergency use

May 19. 2022

"Patients today have more treatment options in the battle against coronavirus disease. The U.S. Food and Drug Administration has approved two drug treatments for COVID-19 and has authorized others for emergency use during this public health emergency. In addition, many more therapies are being tested in clinical trials to evaluate whether they are safe and effective in combating COVID-19.

The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19. This is an intravenous therapy (IV). The FDA has also approved the immune modulator Olumiant (baricitinib) for certain hospitalized adults with COVID-19.

There are also two oral antiviral pills, Paxlovid and Lagevrio (molnupiravir), authorized for patients with mild-to-moderate COVID-19, with strong scientific evidence they can reduce the risk of progressing to severe disease, including hospitalization and death. If you have a positive COVID-19 test and symptoms, contact your health care provider to see if these treatment options are right for you.

the FDA has issued EUAs for several monoclonal antibody treatments for COVID-19 for the treatment, and in some cases prevention (prophylaxis), of COVID-19 in adults and pediatric patients. Monoclonal antibodies are laboratory-made molecules that act as substitute antibodies. They can help your immune system recognize and respond more effectively to the virus, making it more difficult for the virus to reproduce and cause harm.  "

Know Your Treatment Options for COVID-19 | FDA